Revolutionizing Clinical Trials: Digitalization and Innovation in the Age of Pandemics

By Peter Schueler, Innovation in Clinical Trial Methodologies: Lessons Learned during the Corona Pandemic offers a comprehensive guide to the evolution of clinical trials in the digital age. This book is an updated version of Re-Engineering Clinical Trials, focusing on the impact of the COVID-19 pandemic on clinical trial methodologies.

Digitalization and Innovation in Clinical Trials

The COVID-19 pandemic has accelerated the digitalization of various industries, including clinical trials. This book explores the best practices, alternative study concepts, and innovative methods that have emerged as a result. It delves into the design of “virtualized” protocols, moving from data to decisions, and the role of digital technologies in enhancing the efficiency and effectiveness of clinical trials.

Expert Insights for Clinical Researchers

Written by renowned pharmacologists and physicians, Innovation in Clinical Trial Methodologies provides expert, trusted information for those involved in clinical development and trial design. It serves as a valuable resource for researchers seeking to improve patient outcomes, reduce costs, and accelerate the drug development process.

Key Features

• Explores digital and virtual strategies in clinical trials
• Considers best practices, including reduced patient involvement
• Offers insights into moving from data to decisions in clinical trials
• Provides a comprehensive guide to the impact of the COVID-19 pandemic on clinical trial methodologies

A Must-Read for Clinical Researchers

Innovation in Clinical Trial Methodologies is an essential read for pharmacologists, physicians, and clinical researchers. It offers a unique perspective on the future of clinical trials, highlighting the potential of digitalization and innovation to transform the industry.